Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
US Army
McKinsey
Johnson and Johnson
Argus Health
Queensland Health
Julphar
Cantor Fitzgerald

Generated: December 13, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR SIMVASTATIN

« Back to Dashboard

Clinical Trials for Simvastatin

Trial ID Title Status Sponsor Phase Summary
NCT00000553 HDL-Atherosclerosis Treatment Study (HATS) Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 To measure the effects of lipid-lowering drugs and/or antioxidant vitamins on progression or regression of coronary heart disease as measured by quantitative angiography in patients with low high density lipoprotein (HDL) cholesterol.
NCT00000553 HDL-Atherosclerosis Treatment Study (HATS) Completed University of Washington Phase 3 To measure the effects of lipid-lowering drugs and/or antioxidant vitamins on progression or regression of coronary heart disease as measured by quantitative angiography in patients with low high density lipoprotein (HDL) cholesterol.
NCT00000620 Action to Control Cardiovascular Risk in Diabetes (ACCORD) Completed Centers for Disease Control and Prevention Phase 3 The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes mellitus using intensive glycemic control, intensive blood pressure control, and multiple lipid management.
NCT00000620 Action to Control Cardiovascular Risk in Diabetes (ACCORD) Completed National Eye Institute (NEI) Phase 3 The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes mellitus using intensive glycemic control, intensive blood pressure control, and multiple lipid management.
NCT00000620 Action to Control Cardiovascular Risk in Diabetes (ACCORD) Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Phase 3 The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes mellitus using intensive glycemic control, intensive blood pressure control, and multiple lipid management.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Simvastatin

Condition Name

Condition Name for Simvastatin
Intervention Trials
Hypercholesterolemia 82
Dyslipidemia 25
Atherosclerosis 20
Hyperlipidemia 19
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Simvastatin
Intervention Trials
Hypercholesterolemia 95
Dyslipidemias 46
Diabetes Mellitus 35
Coronary Artery Disease 34
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Simvastatin

Trials by Country

Trials by Country for Simvastatin
Location Trials
United States 580
Canada 52
United Kingdom 32
Korea, Republic of 30
Germany 24
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Simvastatin
Location Trials
California 37
Texas 33
Florida 30
New York 28
Maryland 26
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Simvastatin

Clinical Trial Phase

Clinical Trial Phase for Simvastatin
Clinical Trial Phase Trials
Phase 4 107
Phase 3 123
Phase 2/Phase 3 15
[disabled in preview] 82
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Simvastatin
Clinical Trial Phase Trials
Completed 287
Recruiting 54
Unknown status 52
[disabled in preview] 53
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Simvastatin

Sponsor Name

Sponsor Name for Simvastatin
Sponsor Trials
Merck Sharp & Dohme Corp. 87
AstraZeneca 14
GlaxoSmithKline 11
[disabled in preview] 22
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Simvastatin
Sponsor Trials
Other 411
Industry 228
NIH 36
[disabled in preview] 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Moodys
US Department of Justice
Fuji
Julphar
Farmers Insurance
Covington
McKesson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.